Gang Zuo

Gang Zuo

Auto-generated profile, based on publicly available information

Gang Zuo

Department of Neurosurgery, The Affiliated Taicang Hospital, Soochow University, Suzhou, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
GZGang Zuo
Gang Zuo
TZTongyu Zhang
Tongyu Zhang
LHLei Huang
Lei Huang
CACamila Araujo
Camila Araujo
JPJun Peng
Jun Peng
JZJohn Zhang
John Zhang

8 October 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XHXiao Hu
Xiao Hu
SLShirong Li
Shirong Li
DDDesislava Met Doycheva
Desislava Met Doycheva
LHLei Huang
Lei Huang
CLCameron Lenahan
Cameron Lenahan
JZJohn Zhang
John Zhang
Oxidative stress (OS) and neuronal apoptosis are major pathological processes after hypoxic-ischemic encephalopathy (HIE). Colony stimulating factor 1 (CSF1), binding to CSF1 receptor (CSF1R), has been shown to reduce neuronal loss after hypoxic-ischemia- (HI-) induced brain injury. In the present study, we hypothesized that CSF1 could alleviate OS-induced neuronal degeneration and apoptosis through the CSF1R/PLCG2/PKA/UCP2 signaling pathway in a rat model of HI. A total of 127 ten-day old Sprague Dawley rat pups were used. HI was induced by right common carotid artery ligation with subsequent exposure to hypoxia for 2.5 h. Exogenous recombinant human CSF1 (rh-CSF1) was administered intranasally at 1 h and 24 h after HI. The CSF1R inhibitor, BLZ945, or phospholipase C-gamma 2 (PLCG2) inhibitor, U73122, was injected intraperitoneally at 1 h before HI induction. Brain infarct volume measurement, cliff avoidance test, righting reflex test, double immunofluorescence staining, western blot assessment, 8-OHdG and MitoSOX staining, Fluoro-Jade C staining, and TUNEL staining were used. Our results indicated that the expressions of endogenous CSF1, CSF1R, p-CSF1R, p-PLCG2, p-PKA, and uncoupling protein2 (UCP2) were increased after HI. CSF1 and CSF1R were expressed in neurons and astrocytes. Rh-CSF1 treatment significantly attenuated neurological deficits, infarct volume, OS, neuronal apoptosis, and degeneration at 48 h after HI. Moreover, activation of CSF1R by rh-CSF1 significantly increased the brain tissue expressions of p-PLCG2, p-PKA, UCP2, and Bcl2/Bax ratio, but reduced the expression of cleaved caspase-3. The neuroprotective effects of rh-CSF1 were abolished by BLZ945 or U73122. These results suggested that rh-CSF1 treatment attenuated OS-induced neuronal degeneration and apoptosis after HI, at least in part, through the CSF1R/PLCG2/PKA/UCP2 signaling pathway. Rh-CSF1 may serve as therapeutic strategy against brain damage in patients with HIE.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
RGRan Gu
Ran Gu
LWLu Wang
Lu Wang
HZHao Zhou
Hao Zhou
XWXike Wang
Xike Wang
CLCameron Lenahan
Cameron Lenahan
GZGang Zuo
Gang Zuo
Subarachnoid hemorrhage (SAH) is a cerebrovascular disease associated with high morbidity and mortality. CXCR4 provides neuroprotective effects, which can alleviate brain injury and inflammation induced by stroke. Previous studies have suggested that CXCR4 reduces the pyroptosis of LPS‐stimulated BV2 cells. The purpose of this study was to evaluate the antipyroptosis effects and mechanisms of CXCR4 after SAH. SAH animal model was induced via endovascular perforation. A total of 136 male Sprague‐Dawley rats were used. Recombinant human cysteine‐X‐cysteine chemokine ligand 12 (rh‐CXCL‐12) was administered intranasally at 1 h after SAH induction. To investigate the underlying mechanism, the inhibitor of CXCR4, AMD3100, was administered intraperitoneally at 1 h before SAH. The neurobehavior tests were assessed, followed by performing Western blot and immunofluorescence staining. The Western blot results suggested that the expressions of endogenous CXCL‐12, CXCR4, and NLRP1 were increased and peaked at 24 h following SAH. Immunofluorescence staining showed that CXCR4 was expressed on neurons, microglia, and astrocytes. Rh‐CXCL‐12 treatment improved the neurological deficits and reduced the number of FJC‐positive cells, IL‐18‐positive neurons, and cleaved caspase‐1(CC‐1)‐positive neurons after SAH. Meanwhile, rh‐CXCL‐12 treatment increased the levels of CXCL‐12 and CXCR4, and reduced the levels of NLRP1, IL‐18, IL‐1β, and CC‐1. Moreover, the administration of AMD3100 abolished antipyroptosis effects of CXCL‐12 and its regulation of CXCR4 post‐SAH. The CXCR4/NLRP1 signaling pathway may be involved in CXCL‐12‐mediated neuronal pyroptosis after SAH. Early administration of CXCL‐12 may be a preventive and therapeutic strategy against brain injury after SAH.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JDJiaxing Dai
Jiaxing Dai
SXShancai Xu
Shancai Xu
TOTakeshi Okada
Takeshi Okada
YLYu Liu
Yu Liu
GZGang Zuo
Gang Zuo
HSHuaizhang Shi
Huaizhang Shi
Background and Purpose. T0901317, a liver X receptor (LXR) agonist, is widely used to explore the functions of LXRs. T0901317 exerts antiapoptotic effects in many central nervous system disease models. Our aim was to detect the role of T0901317 in neuronal apoptosis in early brain injury after subarachnoid hemorrhage. Methods. Subarachnoid hemorrhage (SAH) models of Sprague‐Dawley rats were established with perforation method. T0901317 was injected intraperitoneally 1‐hour post‐SAH. GSK2033, an inhibitor of LXRs, and interferon regulatory factor (IRF‐1) CRISPR activation were injected intracerebroventricularly to evaluate potential signaling pathway. The severity of SAH, neurobehavior test in both short‐ and long‐term and apoptosis was measured with Western blot and immunofluorescence staining. Results. Expression of LXR‐α and IRF‐1 increased and peaked at 24 h post‐SAH, while LXR‐β remained unaffected in SAH+vehicle group compared with Sham group. Post‐SAH T0901317 treatment attenuated neuronal impairments in both short‐ and long‐term and decreased neuronal apoptosis, the expression of IRF‐1, P53 upregulated modulator of apoptosis (PUMA), dynamin‐1‐like protein (Drp1), Bcl‐2‐associated X protein (Bax) and cleaved caspase‐3, and increasing B‐cell lymphoma 2 (Bcl‐2) at 24 h from modeling. GSK2033 inhibited LXRs and reversed T0901317’s neuroprotective effects. IRF‐1 CRISPR activation upregulated the expression of IRF‐1 and abolished the treatment effects of T0901317. Conclusion. T0901317 attenuated neuronal apoptosis via LXRs/IRF‐1/PUMA/Drp1 pathway in SAH rats.


22 December 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
WSWei Si
Wei Si
BLBanghui Li
Banghui Li
CLCameron Lenahan
Cameron Lenahan
SLShirong Li
Shirong Li
RGRan Gu
Ran Gu
GZGang Zuo
Gang Zuo
Objective. The focus of the present study is to evaluate the effects of Angiotensin II (Ang II) on neuronal apoptosis after HIE and the potential underlying mechanisms. Methods. Primary neonatal rat cortical neurons were used to study the oxygen-glucose deprivation (OGD) cell model. The expressions of Ang II, AT1R, GSK-3β, p-GSK-3β, mTOR, p-mTOR, Bax, Bcl-2, and cleaved caspase-3 were detected via western blot. IF and flow cytometry were used to evaluate neuronal apoptosis. Hypoxic-ischemic encephalopathy (HIE) was established to evaluate the therapeutic effects of Ang II in vivo. Cerebral infarction areas were detected by 2,3,5-Triphenyltetrazolium chloride staining. The righting and geotaxis reflexes were also recorded. In addition, Fluoro-Jade C staining and TUNEL staining were performed to evaluate neuronal degeneration and apoptosis. Results. Ang II significantly increased the rate of neuronal apoptosis, upregulated the expression of cleaved caspase-3, and downregulated Bcl-2/Bax ratio after OGD insult. For vivo assay, the expressions of endogenous Ang II and AT1R gradually increased and peaked at 24h after HIE. Ang II increased NeuN-positive AT1R cell expression. In addition, Ang II increased the area of cerebral infarction, promoted neuronal degeneration and apoptosis, aggravated neurological deficits on righting and geotaxis reflexes, and was accompanied by increased expressions of phosphorylated GSK-3β and mTOR. The application of valsartan (Ang II inhibitor) or SB216763 (GSK-3β inhibitor) reversed these phenomena triggered by Ang II following HIE. Conclusion. Ang II increased neuronal apoptosis through the AT1R/GSK-3β/mTOR signaling pathway after experimental HIE both in vitro and in vivo, and Ang II may serve as a novel therapeutic target to ameliorate brain injury after HIE.